Safety and efficacy of ubrogepant in participants with major cardiovascular risk factors in two single-attack phase 3 randomized trials: ACHIEVE I and II

Susan Hutchinson, Stephen D. Silberstein, Andrew M. Blumenfeld, Richard B. Lipton, Kaifeng Lu, Sung Yun Yu, Lawrence Severt

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'Safety and efficacy of ubrogepant in participants with major cardiovascular risk factors in two single-attack phase 3 randomized trials: ACHIEVE I and II'. Together they form a unique fingerprint.

Medicine & Life Sciences